AR018472A1 - Compuesto, composicion y metodo para el tratamiento de la perdida de cabello - Google Patents

Compuesto, composicion y metodo para el tratamiento de la perdida de cabello

Info

Publication number
AR018472A1
AR018472A1 ARP000100917A ARP000100917A AR018472A1 AR 018472 A1 AR018472 A1 AR 018472A1 AR P000100917 A ARP000100917 A AR P000100917A AR P000100917 A ARP000100917 A AR P000100917A AR 018472 A1 AR018472 A1 AR 018472A1
Authority
AR
Argentina
Prior art keywords
alkyl
heteroalkynyl
heteroalkenyl
heteroalkyl
alkynyl
Prior art date
Application number
ARP000100917A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR018472A1 publication Critical patent/AR018472A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/25—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/75—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Abstract

Compuestos y composiciones particularmente utiles para tratar la pérdida del cabello en mamíferos, incluyendo detener y/o revertir y estimularel crecimiento de éste. Los compuestos tienen una estructura bifenílica (I) y, preferiblemente, no afectan al corazon, en donde: R1, R2, R5, R7 y R10 son cadauno de manera independiente, seleccionados entre hidrogeno, halogeno, alquilo, alquenilo, alquinilo, heteroalquilo, heteroalquenilo y heteroalquinilo;R4 es seleccionado entre el grupo consistente en halogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo,heteroalquenilo, heteroalquinilo, heterocicloalquilo, heterocicloalquenilo, heteroarilo, heteroarilalquilo, y heteroarilalquenilo; con lacondicionde que cuando R2 es hidrogeno, Y es -CH2CHK1, X es seleccionado entre -NZ- y -NH- y R12 es alquilo C1-4, en donde K1 es seleccionada entrehidrogeno y alquilo C1-4 y Z es alquilo C1-4, entonces R4 no sea arilalquilo; R8 y R9 son cada uno de manera independiente, seleccionados entre hidrogeno,halogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo, heteroalquenilo, heteroalquinilo, heterocicloalquilo,heterocicloalquenilo, heteroarilo, heteroarilalquilo y heteroarilalquenilo; con la condicion que por lo menos uno, entre R8 y R9, no sea hidrogeno; R3 esseleccionado entre hidrogeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroalquilo, heteroalquenilo, heteroalquinilo,heterocicloalquilo, heterocicloalquenilo, heteroarilo, heteroarilalquilo y heteroarilalquenilo; Y es seleccionado entre un enlace, alquilo, alquenilo,alquinilo, heteroalquilo, heteroalquenilo y heteroalquinilo; X es seleccionado entre -NZ-, -NH- y -O-; R11 es seleccionado entre un enlace y -C(O)-; con lacondicion que cuando Y es un enlace y X es -O-, luego R11 será -C(O)-; y cuando Y es alquilo y X es -O- entonces R11 no será -C(O)-; R12 es seleccionado entrealquilo, alquenilo, alquinilo, heteroalquilo, heteroalquenilo, heteroalquinilo, cicloalquilo, cicloalquenilo, heterocicloalquilo, heterocicloalquenilo, arilo,
ARP000100917A 1999-06-01 2000-03-01 Compuesto, composicion y metodo para el tratamiento de la perdida de cabello AR018472A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13695899P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
AR018472A1 true AR018472A1 (es) 2001-11-14

Family

ID=22475200

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100917A AR018472A1 (es) 1999-06-01 2000-03-01 Compuesto, composicion y metodo para el tratamiento de la perdida de cabello

Country Status (7)

Country Link
EP (1) EP1183074A1 (es)
JP (1) JP2003500459A (es)
AR (1) AR018472A1 (es)
AU (1) AU3507600A (es)
CA (1) CA2375822A1 (es)
MX (1) MXPA01012491A (es)
WO (1) WO2000072920A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664291B2 (en) 2000-03-31 2003-12-16 Pfizer, Inc. Malonamic acids and derivatives thereof as thyroid receptor ligands
DK1262177T3 (da) * 2001-05-31 2006-11-20 Pfizer Prod Inc Medicinsk brug af thyromimetiske forbindelser til behandling af hårtab og kompositioner
US7169564B1 (en) 2001-06-26 2007-01-30 Anaderm Research Corporation FKBP51/52 and CyP40-mediated mammalian hair growth
DE10131462A1 (de) * 2001-06-29 2003-01-09 Bayer Ag Phenol-Derivate
ES2253495T3 (es) 2001-09-26 2006-06-01 Pfizer Products Inc. Acidos indol carboxilicos como ligandos de receptores tiroideos.
US8741966B2 (en) 2007-11-09 2014-06-03 Pronova Biopharma Norge As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
EP2147910A1 (en) 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
JP5843755B2 (ja) 2009-05-08 2016-01-13 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
SG190114A1 (en) 2010-11-05 2013-07-31 Pronova Biopharma Norge As Methods of treatment using lipid compounds
DK2695611T3 (en) 2012-08-06 2015-01-05 Wolff August Gmbh & Co Kg Arzneimittel Dr Eprotirome for use in the prevention and / or treatment of hair disorders and their compositions
MX2015011074A (es) 2013-02-28 2016-03-09 Pronova Biopharma Norge As Composicion que comprende un compuesto lipido, un triglicerido y un tensioactivo, y metodos de uso de la misma.
JP6784696B2 (ja) 2015-04-28 2020-11-11 プロノヴァ バイオファーマ ノルゲ エーエス 硫黄を含有する構造的に強化された脂肪酸の非アルコール性脂肪性肝炎の予防及び／又は治療のための使用
KR20200096791A (ko) 2017-12-06 2020-08-13 바스프 에이에스 비알콜성 지방간염 치료용 지방산 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69314718T2 (de) * 1992-07-21 1998-02-26 Ciba Geigy Ag Oxamidsäure-Derivate als hypocholesterämische Mittel
EP0812210A4 (en) * 1995-02-23 1998-08-19 Life Medical Sciences Inc COMPOSITIONS AND METHODS FOR INCREASING HAIR GROWTH AND MAINTAINING THE HAIR COLOR

Also Published As

Publication number Publication date
MXPA01012491A (es) 2002-07-02
AU3507600A (en) 2000-12-18
CA2375822A1 (en) 2000-12-07
WO2000072920A1 (en) 2000-12-07
JP2003500459A (ja) 2003-01-07
EP1183074A1 (en) 2002-03-06

Similar Documents

Publication Publication Date Title
AR018472A1 (es) Compuesto, composicion y metodo para el tratamiento de la perdida de cabello
PA8546301A1 (es) Resolucion de sal quiral
DE50009643D1 (de) Tensidzusammensetzung enthaltend geminitenside und co-amphiphile, ihre herstellung und ihre verwendung
AR008384A1 (es) Composicion topica para el tratamiento de condiciones de la piel, uso del compuesto para la preparacion de un medicamento y metodo no-terapeuticos para el pulido de la piel y de suavizante capilar .
AR006867A1 (es) Composición topica para la piel que comprende un compuesto oxa-diácido, su uso para preparar un medicamento para tratar condiciones de la piel y métodos cosméticos no terapéuticos para el pulido de la piel y para suavizar el cabello que aplican dicho compuesto.
AR042461A1 (es) Analogos 2-sustituidos de quinazolin-4-il - amina. composiciones farmaceuticas
DK0736039T3 (da) Forbindelser med væksthormon-frigivende egenskaber
PE20001303A1 (es) Derivados de la 4-aroilpiperidina como antagonistas del receptor ccr-3
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
GT199900067A (es) Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica.
PE20000422A1 (es) Compuestos de amidina
PE20011047A1 (es) Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas
PE129099A1 (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos
UY23835A1 (es) Procedimiento para la preparacion de compuesto de acilo
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
CR6592A (es) Compuestos para el tratamiento de la isquemia
ES8600737A1 (es) Procedimiento de preparar compuestos de sulfonio
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
SE9702564D0 (sv) New compounds
ATE173625T1 (de) Zusammensetzungen zur behandlung von hiv- infektionen
AR018700A1 (es) Compuesto, composicion y metodo para el tratamiento de la perdida del cabello
DE69333413D1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
ES2043891T3 (es) Procedimiento para preparar nuevos agentes antiarritmicos ii.
AR018164A1 (es) Proceso para la preparacion de cis-ciclohexilidenaminas
SE9702563D0 (sv) Compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal